HEMGENIX ®, the first and only FDA-approved gene therapy for adults with hemophilia B, wins for Best Product for Rare/Orphan Diseases "CSL is humbled and honored to receive a Prix Galien award for ...

WHARTON, N.J., Dec. 11, 2025 /PRNewswire/ -- DMI Solutions announced it has acquired the proprietary process and ingredient technology of Leading Edge Innovations in a move that further expands its ...

Pipeline advancements and investment in innovation and disruptive technologies to help fuel sustainable, profitable growth for CSL's three businesses, CSL Behring, CSL Seqirus and CSL Vifor, in the ...